Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Guerry

Showing results (61-70 of 113) with videos related to

Pageof 12
Sort By:
Surgical Oncology|October 11, 1992
Loco-regional nodal relapse in melanomaE J Miller, J M Daly, M Synnestvedt, et al.
The Journal of Investigative Dermatology|October 27, 1997
Radiation-induced chromatid breaks and DNA repair in blood lymphocytes of patients with dysplastic nevi and/or cutaneous melanomaK K Sanford, R Parshad, F M Price, et al.
Plos One|December 21, 2017
Habitat risk assessment for regional ocean planning in the U.S. Northeast and Mid-AtlanticKatherine H Wyatt, Robert Griffin, Anne D Guerry, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1983
Functional consequence of variation in melanoma antigen expressionL M Zehngebot, M A Alexander, D Guerry, et al.
International Journal of Cancer|January 11, 2000
CD4(+), HLA class I-restricted, cytolytic T-lymphocyte clone against primary malignant melanoma cellsR Somasundaram, P Robbins, D Moonka, et al.
Journal of General Internal Medicine|January 1, 1987
"Catalyst" symptoms in malignant melanomaB R Cassileth, E J Lusk, D Guerry, et al.
Cancer Research|September 25, 1991
Characterization of tenascin secreted by human melanoma cellsM Herlyn, U Graeven, D Speicher, et al.
Lancet (London, England)|November 5, 1983
Dysplastic naevi and cutaneous melanoma riskK H Kraemer, M H Greene, R Tarone, et al.
Cancer Research|March 1, 1986
Human cutaneous nevi transplanted onto nude mice: a model for the study of the lesional steps in tumor progressionD Herlyn, D E Elder, E Bondi, et al.
Journal of the American Academy of Dermatology|June 1, 1990
Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier diseaseG D Masri, W H Clark, D Guerry, et al.
Pageof 12

Showing results (61-70 of 113) with videos related to

Sort By:
Pageof 12
Surgical Oncology|October 11, 1992
Loco-regional nodal relapse in melanomaE J Miller, J M Daly, M Synnestvedt, et al.
The Journal of Investigative Dermatology|October 27, 1997
Radiation-induced chromatid breaks and DNA repair in blood lymphocytes of patients with dysplastic nevi and/or cutaneous melanomaK K Sanford, R Parshad, F M Price, et al.
Plos One|December 21, 2017
Habitat risk assessment for regional ocean planning in the U.S. Northeast and Mid-AtlanticKatherine H Wyatt, Robert Griffin, Anne D Guerry, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1983
Functional consequence of variation in melanoma antigen expressionL M Zehngebot, M A Alexander, D Guerry, et al.
International Journal of Cancer|January 11, 2000
CD4(+), HLA class I-restricted, cytolytic T-lymphocyte clone against primary malignant melanoma cellsR Somasundaram, P Robbins, D Moonka, et al.
Journal of General Internal Medicine|January 1, 1987
"Catalyst" symptoms in malignant melanomaB R Cassileth, E J Lusk, D Guerry, et al.
Cancer Research|September 25, 1991
Characterization of tenascin secreted by human melanoma cellsM Herlyn, U Graeven, D Speicher, et al.
Lancet (London, England)|November 5, 1983
Dysplastic naevi and cutaneous melanoma riskK H Kraemer, M H Greene, R Tarone, et al.
Cancer Research|March 1, 1986
Human cutaneous nevi transplanted onto nude mice: a model for the study of the lesional steps in tumor progressionD Herlyn, D E Elder, E Bondi, et al.
Journal of the American Academy of Dermatology|June 1, 1990
Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier diseaseG D Masri, W H Clark, D Guerry, et al.
Pageof 12